1. Home
  2. KOD vs IRMD Comparison

KOD vs IRMD Comparison

Compare KOD & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • IRMD
  • Stock Information
  • Founded
  • KOD 2009
  • IRMD 1992
  • Country
  • KOD United States
  • IRMD United States
  • Employees
  • KOD N/A
  • IRMD N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • IRMD Medical/Dental Instruments
  • Sector
  • KOD Health Care
  • IRMD Health Care
  • Exchange
  • KOD Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • KOD 795.5M
  • IRMD 910.4M
  • IPO Year
  • KOD 2018
  • IRMD 2014
  • Fundamental
  • Price
  • KOD $16.43
  • IRMD $84.54
  • Analyst Decision
  • KOD Buy
  • IRMD Strong Buy
  • Analyst Count
  • KOD 7
  • IRMD 1
  • Target Price
  • KOD $19.29
  • IRMD $72.00
  • AVG Volume (30 Days)
  • KOD 964.2K
  • IRMD 76.2K
  • Earning Date
  • KOD 11-13-2025
  • IRMD 11-03-2025
  • Dividend Yield
  • KOD N/A
  • IRMD 0.81%
  • EPS Growth
  • KOD N/A
  • IRMD 13.00
  • EPS
  • KOD N/A
  • IRMD 1.65
  • Revenue
  • KOD N/A
  • IRMD $80,511,268.00
  • Revenue This Year
  • KOD N/A
  • IRMD $12.93
  • Revenue Next Year
  • KOD N/A
  • IRMD $11.26
  • P/E Ratio
  • KOD N/A
  • IRMD $50.82
  • Revenue Growth
  • KOD N/A
  • IRMD 12.91
  • 52 Week Low
  • KOD $1.92
  • IRMD $47.48
  • 52 Week High
  • KOD $21.17
  • IRMD $87.88
  • Technical
  • Relative Strength Index (RSI)
  • KOD 48.57
  • IRMD 66.35
  • Support Level
  • KOD $17.04
  • IRMD $75.75
  • Resistance Level
  • KOD $19.26
  • IRMD $87.82
  • Average True Range (ATR)
  • KOD 1.79
  • IRMD 3.20
  • MACD
  • KOD -0.40
  • IRMD 0.64
  • Stochastic Oscillator
  • KOD 5.00
  • IRMD 76.57

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: